South Africa’s Aspen says on track to dispose of baby milk business
JOHANNESBURG: Aspen Pharmacare said on Thursday it expected the conditions for the sale of its infant formula business to be in place by the first quarter of 2019. The drugmaker’s…
Heat-Stable Carbetocin To Be Available In India By 2019 End
New Delhi: While the Central government is getting ready to restrict private companies from making or distributing oxytocin, a life-saving drug administered to pregnant women to prevent and treat postpartum…
DTAB Approves Regulatory Provisions For Online Medicine Sales
New Delhi: In a fillip to e-pharmacies that are facing multiple lawsuits over their legal status, the Drug Technical Advisory Body (DTAB), the country’s highest drug advisory body on technical…
Rusan Pharma launches Parkinson’s Disease drug
New Delhi: Drug maker Rusan Pharma Thursday said it has launched a drug to treat Parkinson’s disease. The drug — Aposan — is used to treat motor fluctuations in patients…
Jury convicts ex-employees of pharmacy in U.S. meningitis outbreak
By Nate Raymond BOSTON: A co-owner and four ex-employees of a Massachusetts compounding pharmacy were convicted on Thursday of committing frauds and other illegal activities that helped boost its business…
Samples Of Oral Polio Vaccine Found Adulterated: MoS Health
New Delhi :Two samples of a batch of bivalent oral polio vaccine (bOPV) were found to be adulterated and containing type 2 polio virus by the Central Drugs Laboratory (CDL),…
FDA declines to approve reformulated Mallinckrodt opioid
Mallinckrodt Plc said on Wednesday the U.S. Food and Drug Administration declined to approve an abuse-deterrent version of its opioid painkiller Roxicodone. Certain parts of the company’s application need further…
Sebi examining whistleblower complaint against Sun Pharma: Tyagi
Mumbai: Markets regulator Sebi Wednesday said it is examining the whistleblower complaint against Dilip Shanghvi-led Sun Pharmaceutical Industries. A whistleblower had last month approached Sebi with a document alleging various…
J&J says its psoriasis drug superior to Novartis’ in study
Johnson & Johnson said on Wednesday its drug Tremfya was more effective than a rival medicine from Novartis AG, and met the main goal of a late-stage study in adults…
EU Court upholds 40 mn euro fine on Lupin over Perindopril litigation
New Delhi: Drug maker Lupin Wednesday said a court in Europe has upheld a decision to impose a fine of 40 million euros (over Rs 325 crore) on the company…
